Publication

Article

Cardiology Review® Online

May 2006
Volume23
Issue 5

Continuing Medical Education Exam

Target: Diabetes • CAD/Angina

“Undiagnosed diabetes mellitus in coronary artery bypass graft surgery”

Profile the prevalence and risks of undiagnosed diabetes mellitus in a population of coronary bypass patients and its impact on the perioperative and postoperative outcomes.

Learning objectives

Questions

1. In the Lauruschkat study, resuscitation after coronary artery bypass graft (CABG) surgery was required for _____of patients with undiagnosed diabetes versus 1.5% of patients with diabetes and 1.7% of patients without diabetes.

a 2.2%

b 4.2%

c 6.2%

d 8.2%

2. The perioperative mortality rate was _____for patients with undiagnosed diabetes, compared with patients with and without diabetes.

a higher

b lower

c similar

d statistically identical

3. Coronary artery bypass graft surgery patients without diabetes in the Lauruschkat study had ________than patients with diabetes.

a lower high-density lipoprotein

b higher low-density lipoprotein

c higher ejection fractions

d lower stress hyperglycemia

4. Levetan and colleagues found that____ of 1034 patients hospitalized in an urban, tertiary-care teaching hospital were found to have undiagnosed diabetes on admission.

a 25%

b 33%

c 50%

d 66%

5. In Lauruschkat’s study, the percentage of CABG surgery patients with known diabetes was_____, while the prevalence of patients with undiagnosed diabetes mellitus was_____.

a 39.3%; 2.1%

b 35.6%; 3.2%

c 32.3%; 4.1%

d 29.6%; 5.2%

Target: Lipid Disorders • Stroke

“Elevated high-density lipoprotein cholesterol and carotid atherosclerosis”

Examine the relationship between high-density lipoprotein (HDL) cholesterol and carotid plaque progression and the mechanisms by which HDL cholesterol counteracts plaque growth.

Learning objectives

1. High-density lipoprotein (HDL) cholesterol may exert its protective effects by

Questions

a indirectly buffering vessel injuries.

b improving the oxidation of lipoprotein.

c returning low-density lipoprotein (LDL) back to the liver from the atheroma.

d promoting the development of echogenic plaques.

Plaques that contain fewer cellular components, more connective tissue (collagen), and varying degrees of calcification are noted by

a high absorption of ultrasound energy

b high gray-scale mediam (GSM)

c low GSM

d a gray appearance on the ultrasound monitor.

2.

3. Plaque growth was inversely associated with

a age

b systolic blood pressure

c current smoking

d HDL cholesterol level

4. The plaques with a lower growth rate tended to become

a less echogenic

b less echolucent.

c more echogenic

d more echolucent.

5. ______ particles may transform plaques into more fibrotic lesions and thereby thwart their growth by removing ________ from the vessel wall.

a HDL cholesterol; LDL cholesterol

b LDL cholesterol; HDL cholesterol

c HDL cholesterol; cholesteryl ester

d HDL cholesterol; lecithin-cholesterol acyltransferase

If you wish to take this test on line, please visit

and complete the post-test and evaluation form.

www.cme.uc.edu

Related Videos
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Nathan D. Wong, MD, PhD: Growing Role of Lp(a) in Cardiovascular Risk Assessment | Image Credit: UC Irvine
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Laurence Sperling, MD: Multidisciplinary Strategies to Combat Obesity Epidemic | Image Credit: Emory University
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orly Vardeny, PharmD: Finerenone for Heart Failure with EF >40% in FINEARTS-HF | Image Credit: JACC Journals
Matthew J. Budoff, MD: Impact of Obesity on Cardiometabolic Health in T1D | Image Credit: The Lundquist Institute
Matthew Weir, MD: Prioritizing Cardiovascular Risk in Chronic Kidney Disease | Image Credit: University of Maryland
Erin Michos, MD: HFpEF in Women and Sex-Specific Therapeutic Approaches | Image Credit: Johns Hopkins
© 2024 MJH Life Sciences

All rights reserved.